823 related articles for article (PubMed ID: 15630413)
21. Galectins in apoptosis.
Hsu DK; Yang RY; Liu FT
Methods Enzymol; 2006; 417():256-73. PubMed ID: 17132510
[TBL] [Abstract][Full Text] [Related]
22. Galectins in acute and chronic inflammation.
Liu FT; Yang RY; Hsu DK
Ann N Y Acad Sci; 2012 Apr; 1253():80-91. PubMed ID: 22329844
[TBL] [Abstract][Full Text] [Related]
23. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
24. Tumor galectinology: insights into the complex network of a family of endogenous lectins.
Lahm H; André S; Hoeflich A; Kaltner H; Siebert HC; Sordat B; von der Lieth CW; Wolf E; Gabius HJ
Glycoconj J; 2004; 20(4):227-38. PubMed ID: 15115907
[TBL] [Abstract][Full Text] [Related]
25. Tissue transglutaminase in tumour progression: friend or foe?
Kotsakis P; Griffin M
Amino Acids; 2007 Aug; 33(2):373-84. PubMed ID: 17581697
[TBL] [Abstract][Full Text] [Related]
26. Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.
Laderach DJ; Compagno D; Toscano MA; Croci DO; Dergan-Dylon S; Salatino M; Rabinovich GA
IUBMB Life; 2010 Jan; 62(1):1-13. PubMed ID: 20014236
[TBL] [Abstract][Full Text] [Related]
27. Galectins in the tumor endothelium: opportunities for combined cancer therapy.
Thijssen VL; Poirier F; Baum LG; Griffioen AW
Blood; 2007 Oct; 110(8):2819-27. PubMed ID: 17591944
[TBL] [Abstract][Full Text] [Related]
28. Galectin-1 as a potential cancer target.
Rabinovich GA
Br J Cancer; 2005 Apr; 92(7):1188-92. PubMed ID: 15785741
[TBL] [Abstract][Full Text] [Related]
29. The role of galectins in protein trafficking.
Delacour D; Koch A; Jacob R
Traffic; 2009 Oct; 10(10):1405-13. PubMed ID: 19650851
[TBL] [Abstract][Full Text] [Related]
30. A distinctive role for galectin-7 in cancer ?
St-Pierre Y; Campion CG; Grosset AA
Front Biosci (Landmark Ed); 2012 Jan; 17(2):438-50. PubMed ID: 22201754
[TBL] [Abstract][Full Text] [Related]
31. Vascular galectins: regulators of tumor progression and targets for cancer therapy.
Thijssen VL; Rabinovich GA; Griffioen AW
Cytokine Growth Factor Rev; 2013 Dec; 24(6):547-58. PubMed ID: 23942184
[TBL] [Abstract][Full Text] [Related]
32. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death.
Perillo NL; Marcus ME; Baum LG
J Mol Med (Berl); 1998 May; 76(6):402-12. PubMed ID: 9625297
[TBL] [Abstract][Full Text] [Related]
33. Role of galectins in lung cancer.
Chang WA; Tsai MJ; Kuo PL; Hung JY
Oncol Lett; 2017 Nov; 14(5):5077-5084. PubMed ID: 29113148
[TBL] [Abstract][Full Text] [Related]
34. Galectins in angiogenesis: consequences for gestation.
Blois SM; Conrad ML; Freitag N; Barrientos G
J Reprod Immunol; 2015 Apr; 108():33-41. PubMed ID: 25622880
[TBL] [Abstract][Full Text] [Related]
35. Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis.
Bannoud N; García PA; Gambarte-Tudela J; Sundblad V; Cagnoni AJ; Bach CA; Pérez Saez JM; Blidner AG; Maller SM; Mariño KV; Salatino M; Cerliani JP; Rabinovich GA; Croci DO
Methods Mol Biol; 2022; 2442():635-653. PubMed ID: 35320550
[TBL] [Abstract][Full Text] [Related]
36. Roles of galectins in inflammatory bowel disease.
Hokama A; Mizoguchi E; Mizoguchi A
World J Gastroenterol; 2008 Sep; 14(33):5133-7. PubMed ID: 18777589
[TBL] [Abstract][Full Text] [Related]
37. Galectins-A Potential Target for Cardiovascular Therapy.
Ashraf GM; Perveen A; Zaidi SK; Ahmad A; Shakil S; Firoz CK; Jabir NR; Hassan I; Khan TA; Yarla NS; Tabrez S
Curr Vasc Pharmacol; 2017; 15(4):296-312. PubMed ID: 28155611
[TBL] [Abstract][Full Text] [Related]
38. [Galectins in hematological malignancies--role, functions and potential therapeutic targets].
Wdowiak K; Spychałowicz W; Fajkis M; Wojnar J
Postepy Hig Med Dosw (Online); 2016 Feb; 70():95-103. PubMed ID: 26943306
[TBL] [Abstract][Full Text] [Related]
39. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
Saussez S; Camby I; Toubeau G; Kiss R
Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
[TBL] [Abstract][Full Text] [Related]
40. Galectins: novel anti-inflammatory drug targets.
Liu FT
Expert Opin Ther Targets; 2002 Aug; 6(4):461-8. PubMed ID: 16353421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
